Compare Twist Bioscience Corp (TWST) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Visa Inc — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while Visa Inc trades at $356.84 (market cap $685.71B). The key difference: Visa Inc is far larger — about 125.8× Twist Bioscience Corp's market cap, and Visa Inc pays a 0.74% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TWST | V | |
|---|---|---|
Market Cap | $5.45B | $685.71B |
Sector | Health | Financials |
52-Week High | $102.88 | $365.14 |
52-Week Low | $24.16 | $295.52 |
Enterprise Value | $5.37B | $696.30B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Visa (V) trades at $355.85, down 0.76% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $396.70 implying 11.5% upside. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $3.31 exceeding the $3.10 estimate, and maintains robust profitability with a net income margin over 51%. Recent news highlights Visa's focus on AI-driven commerce and stablecoin partnerships to enhance its payment network.
Visa's outlook remains positive due to consistent earnings growth, high margins, and strategic initiatives in AI and digital payments. Key risks include competitive pressures from fintech and regulatory scrutiny. With 85% of analysts rating it a Buy and institutional ownership increasing, the stock presents a compelling long-term opportunity, though investors should monitor execution on innovation and macroeconomic impacts on consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
